Gil Redelman-Sidi, MD
Infectious Diseases Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Infectious Diseases
- Management of Infections and Infectious Complications of Cancer or Its Treatment
Request an Appointment
About Me
- Assistant Attending Physician
I am an internist and infectious disease specialist with a special interest in the care of patients with infections related to cancer or its treatment. I am particularly interested in treating mycobacterial infections among immunocompromised patients, including infections with nontuberculous mycobacteria.
Read more
The focus of my laboratory research is the use of Bacillus Calmette-Guerin (BCG), a bacterium normally used as a vaccine against tuberculosis, as an immunotherapy for bladder cancer. The aim of my research is to understand the mechanism of action of BCG, with the long-term goal of translating this understanding into improved care for patients with early-stage bladder cancer.
In the past several years, the field of cancer immunotherapy has expanded far beyond BCG therapy for bladder cancer. These exciting new therapies are associated with robust response rates, but the full extent of side effects associated with these agents is yet unknown. My fascination with BCG immunotherapy of bladder cancer has also led to an interest in these novel methods of immunotherapy, and I have embarked on a study of infections among patients receiving various forms of cancer immunotherapy.
An infectious diseases specialist is a doctor with special training in diseases caused by microorganisms (bacteria, fungi, parasites, and viruses).
My Specialties
- Infectious Diseases
- Management of Infections and Infectious Complications of Cancer or Its Treatment
Education
- MD, Sackler School of Medicine (Israel)
Residencies
- Jacobi Medical Center (New York)
Fellowships
- Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Infectious Disease
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Redelman-Sidi sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
View Dr. Redelman-Sidi's Research
Visit PubMed for a full listing of Gil Redelman-Sidi’s journal articles.
Books and Book Chapters
“Patients with Cancer or Hematopoietic Stem Cell Transplant: Infection with 2009H1N1 Influenza.” Redelman-Sidi G. Chapter 38 in Stem Cells and Cancer Stem Cells: Therapeutic Applications in Disease and Injury, Volume 2. MA Hayat, ed. Springer 2012.
“Rhodotorual Species.” Gil Redelman-Sidi, Susan K. Seo, Arthur E. Brown. In Antimicrobial Therapy and Vaccines; Volume 1: Microbes (www.antimicrobe.org). Yu VL, et al, editors. ESun Technologies, Pittsburgh, PA, 2007.
“Relapsing Fever,” Gil Sidi, Eli Schwartz. Chapter 19 in Tropical Diseases in Travelers, E. Schwartz. Wiley-Blackwell, July 2009.
Patient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Gil Redelman-Sidi discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
